Skip to Main content Skip to Navigation
Journal articles

Polatuzumab Vedotin Combined with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) for Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results of a Phase Ib Dose-Escalation

Abstract : Conference: 57th Annual Meeting of the American-Society-of-Hematology - Orlando, FL - DEC 05-08, 2015
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01290426
Contributor : Laurent Jonchère <>
Submitted on : Friday, March 18, 2016 - 10:30:15 AM
Last modification on : Wednesday, May 16, 2018 - 11:23:19 AM

Identifiers

  • HAL Id : hal-01290426, version 1

Citation

Nancy L. Bartlett, Andy I. Chen, Kathryn S. Kolibaba, Thierry Lamy, Surai Jones, et al.. Polatuzumab Vedotin Combined with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) for Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results of a Phase Ib Dose-Escalation. Blood, American Society of Hematology, 2015, 126 (23), pp.2726. ⟨hal-01290426⟩

Share